Keele Research Repository

Article

Rifkin-Zybutz, R, MacNeill, S, Davies, SJ, Dickens, C, Campbell, J, Anderson, IM, Chew-Graham, CA ORCID: https://orcid.org/0000-0002-9722-9981, Peters, TJ, Lewis, G, Wiles, N and Kessler, D (2020) Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial. Journal of Psychopharmacology, 34 (12). 1342 - 1349.

Divakar, U, Nazeha, N, Posadzki, P, Jarbrink, K, Bajpai, R ORCID: https://orcid.org/0000-0002-1227-2703, Ho, AHY, Campbell, J, Feder, G and Car, J (2019) Digital Education of Health Professionals on the Management of Domestic Violence: Systematic Review and Meta-Analysis by the Digital Health Education Collaboration. Journal of Medical Internet Research, 21 (5). e13868 -e13868.

Car, J, Carlstedt-Duke, J, Tudor Car, L, Posadzki, P, Whiting, P, Zary, N, Atun, R, Majeed, A, Campbell, J and Digital Health Education Collaboration, . (2019) Digital Education in Health Professions: The Need for Overarching Evidence Synthesis. Journal of Medical Internet Research, 21. e12913 - e12913.

Kessler, D, Burns, A, Tallon, D, Lewis, G, MacNeill, S, Round, J, Hollingworth, W, Chew-Graham, CA, Anderson, I, Campbell, J, Dickens, C, Macleod, U, Gilbody, S, Davies, S, Peters, TJ and Wiles, N (2018) Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Health Technology Assessment, 22 (63). 1 - 136.

Kessler, DS, MacNeil, SJ, Tallon, D, Lewis, G, Peters, TJ, Hollingworth, W, Round, J, Burns, A, Chew-Graham, CA, Anderson, IM, SHEPHERD, T, Campbell, J, Dickens, CM, Carter, M, Jenkinson, C, Macleod, U, Gibson, H, Davies, S and Wiles, NJ (2018) MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR). BMJ, 363.

Kessler, DS, MacNeill, SJ, Tallon, D, Lewis, G, Peters, TJ, Hollingworth, W, Round, J, Burns, A, Chew-Graham, CA, Anderson, IM, Shepherd, T, Campbell, J, Dickens, CM, Carter, M, Jenkinson, C, Macleod, U, Gibson, H, Davies, S and Wiles, NJ (2018) Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). BMJ, 363. k4218 - ?.

O'Donnell, CA, Rosenthal, J, Moore, M, Francis, N, Sharp, D, Jones, R, Mallen, CD ORCID: https://orcid.org/0000-0002-2677-1028 and Campbell, J (2017) General practice needs ongoing commitment to training budgets. BMJ, 357. j2401 - ?.

Williams, DJ, Archer, R, Archibald, P, Bantounas, I, Baptista, R, Barker, R, Barry, J, Bietrix, F, Blair, N, Braybrook, J, Campbell, J, Canham, M, Chandra, A, Foldes, G, Gilmanshin, R, Girard, M, Gorjup, E, Hewitt, Z, Hourd, P, Hyllner, J, Jesson, H, Kee, J, Kerby, J, Kotsopoulou, N, Kowalski, S, Leidel, C, Marshall, D, Masi, L, McCall, M, McCann, C, Medcalf, N, Moore, H, Ozawa, H, Pan, D, Parmar, M, Plant, AL, Reinwald, Y, Sebastian, S, Stacey, G, Thomas, RJ, Thomas, D, Thurman-Newell, J, Turner, M, Vitillio, L, Wall, I, Wilson, A, Wolfrum, J, Yang, Y and Zimmerman, H (2016) Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015. Regenerative Medicine, 11 (5). 483 - 492.

Tallon, D, Wiles, N, Campbell, J, Chew-Graham, CA, Dickens, C, Macleod, U, Peter, TJ, Lewis, G, Anderson, IM, Gilbody, S, Hollingworth, W, Davies, SJ and Kessler, D (2016) Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial. Trials, 17 (1). p. 66.